HOME
ABOUT
About US
Corporate culture
Company honor
Development course
PRODUCT
Drugs in the field of tumor-re
Drugs in other fields
Health care products
R&d innovation
R&d pipeline
R&d progress
Patient recruitment
NEWS
Company dynamics
Trade news
Academic exchanges
INVESTOR
Latest announcement
H&R
Job development
Talent recruitment
CONTACT
Notice
EN
CN
HOME
ABOUT
About US
Corporate culture
Company honor
Development course
PRODUCT
Drugs in the field of tumor-re
Drugs in other fields
Health care products
R&d innovation
R&d pipeline
R&d progress
Patient recruitment
NEWS
Company dynamics
Trade news
Academic exchanges
INVESTOR
INVESTOR
Latest announcement
H&R
Job development
Talent recruitment
CONTACT
Notice
Shengbai oral liquid (mixture) was included in the "Interpretation of Traditional Chinese Medicine Diagnosis and Treatment Plans and Paths"
2020-03-30
PREV
Shengbai oral liquid (mixture) was included in the textbook of "Hematology of Traditional Chinese Medicine".
NEXT
Mengyang Pharmaceutical announced the results of the Phase I registration clinical trial of DH001, the world's first oral cardioprotective agent (reducing doxorubicin cardiotoxicity), in China
Hot news
How much do you know about leukopen...
Meta-analysis of the efficacy of S...
A complete TCM treatment for leu...
Efficacy of Shengbai mixture on bo...
Should leukopenia be discontinued i...
Should I stop chemotherapy if I h...
What kind of treatment is needed fo...
Polysaccharides were included in th...